Multimodal Nephrology Care
Kidney Disease
CommercialActive
Key Facts
About Medice
Medice is a well-established, privately-held German pharmaceutical company with over 75 years of history, transitioning from a traditional drug developer to an integrated 'Health Family' provider. Its core business is the development, manufacturing, and international commercialization of small molecule therapeutics, primarily in ADHD, nephrology, urology, and self-medication. The company is strategically expanding beyond pure pharmaceuticals into multimodal healthcare, including digital health applications (DiGA) and nutritional concepts, aiming to create comprehensive treatment ecosystems. With over 1,000 employees and a strong international distribution network, Medice is on a long-term growth trajectory.
View full company profileTherapeutic Areas
Other Kidney Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| NOX4 Inhibitor Platform | Glucox Biotech | Research |
| Undisclosed | R1 Therapeutics | Pre-clinical |
| USP30 Inhibitor Program | Vincere Biosciences | Preclinical |
| MSC-Klotho | Kyttaro | Pre-clinical |